期刊文献+

土耳其斯坦裂体吸虫23kDa蛋白基因的序列分析及抗原表位预测 被引量:2

Bioinformatics Prediction on Antigen Epitopes and Sequence Analysis of 23 kDa Genes of Schistosoma turkestanicum
下载PDF
导出
摘要 为研究土耳其斯坦裂体吸虫23 kDa蛋白的生物学特性,以土耳其斯坦裂体吸虫cDNA为模版,利用PCR对23 kDa基因进行扩增,并将其克隆到T-easy载体后进行序列测定。利用生物信息学对其结构、抗原指数进行分析,并对其抗原表位进行预测。序列分析结果表明,该虫体的23 kDa基因长度为657 bp,A+T含量为57.38%,与曼氏血吸虫、埃及血吸虫和日本血吸虫的23 kDa基因的相似性分别为85.24%、83.71%和81.89%。蛋白二级结构分析表明,23 kDa蛋白经过4次跨膜,主要由6个α-螺旋、3个β-折叠、7个β转角和若干个无规则卷曲构成。抗原表位预测结果表明,该蛋白有3个B细胞抗原表位。综合分析土耳其斯坦裂体吸虫23 kDa蛋白是一种较好的抗原分子,是土耳其斯坦裂体吸虫疫苗的重要候选分子。 The 23 kDa gene was amplified from individual Schistosoma turkestanicum worm eDNA by polymerase chain reaction (PCR),and the positive PCR products were cloned into the T-easy vector and sequenced,which would help to examine the biological characteristics of 23 kDa protein. The structure and antigen index of the 23 kDa protein were analyzed by bioinformatics method,and the antigen epitopes were predicted. The sequence analysis showed that the complete 23 kDa gene sequence of S. turkestanicum was 657 bp in length ,and the content of A+T was 57.38%. Compared with the corresponding nucleic acid sequence of S. mar^oni,S, haematobium and S. japonicum,the 23 kDa gene of S.turkestanicum's mutation probability were 85.24%,83.71% and 81.89%,respectively. The secondary structure analysis showed that the 23 kDa protein was tetraspanin,the mainly composed of six alpha helix,three Beta sheet, seven β-bend, and several random coil,and prediction on antigen epitopes indicated that 23 kDa protein had 3 B cell antigen epitope. In conclusion,the present study revealed that 23 kDa protein of S.turkestanicum's was a good antigen and the potential candidate for vaccines development against S.turkestanicum.
出处 《黑龙江八一农垦大学学报》 2014年第4期26-29,共4页 journal of heilongjiang bayi agricultural university
基金 黑龙江省教育厅科研项目(11551311)
关键词 土耳其斯坦裂体吸虫 23 kDa基因 序列分析 表位预测 Schistosoma turkestanicum 23 kDa gene sequence analysis prediction on antigen epitopes
  • 相关文献

参考文献8

  • 1Wang C R,Chen J,Zhao J P,et al. Orientobilharziaspecies:Neglected parasitic zoonotic agents[j]. Acta Trop, 2009,109(3):171-175.
  • 2Wright M D,Henkle K J,Mitchell G F. An immunogenic Mr23,000 intergral membrane protein of schistosoma mansoni worms that closely resembles a human tumor -associated antigen [j]. J Immunol, 1990,144 (8):3195-3200.
  • 3Jiang N,Cai P,Yin J,et al. Characterization of antibody responses to the Sj23 antigen of Schistosoma japonicum after infection and immunization [J]. Acta tropica, 2010,116(1):9-14.
  • 4McManus D P. The search for a vaccine against schistosomiasis-a difficult path but an achievable goal [J]. Immunol Rev, 1999,171( 1) : 149-161.
  • 5焦文强,关洪鑫,殷相平,柳纪省.狂犬病病毒aG株G基因的克隆与生物信息学分析[J].中国兽医科学,2012,42(3):221-226. 被引量:3
  • 6Loukas A,Tran M,Pearson MS. Schistosome membrane proteins as vaccines [J]. Int J Parasitol,2007,37 ( 3/4): 257-263.
  • 7Zhu Y,Ren J,Da, dara A. The protective effect of a Schistosoma japonicum Chinese strain 23 kDaa plasmid DNA vaccine in pigs is enhanced with IL -12 [J]. Vaccine,2004,23(1): 78-83.
  • 8田思勤,张艳,常巧呈,朱兴全,王春仁.两种兔艾美耳球虫顶质体rpoB和TufA基因的扩增及序列分析[J].黑龙江八一农垦大学学报,2014,26(2):40-43. 被引量:5

二级参考文献30

  • 1张维,刘群.顶复门寄生虫顶质体的研究进展[J].中国兽医科学,2006,36(8):674-678. 被引量:5
  • 2TORDO N,POCH O,ERMINE A,et al.Walking along therabies virus genome:is the large G-L intergenic region a rem-nant gene[J].Proc Natl Acad Sci USA,1986,83(11):3914-3918.
  • 3GAUDIN Y,RUIGROK R W,TUFFEREAU C,et al.Rabiesvirus glycoprotein is a trimer[J].Virology,1992,187(2):627-632.
  • 4ETESSAMI R,CONZELMANN K K,FADAI-GHOTBI B,etal.Spread and pathogenic characterization of a G-deficient ra-bies virus recombinant:an in vitro and in vivo study[J].J GenVirol,2000,81(9):2147-2153.
  • 5MAZARAKIS N D,AZZOUZ M,ROHLL J B,et al.Rabiesvirus glycoprotein pseudotyping of lentiviral vectors enablesretrograde axonal transport and access to the nervous systemafter peripheral delivery[J].Hum Mol Genet,2001,10(19):2109-2121.
  • 6YAN X,MOHANKUMAR P S,DIETZSCHOLD B,et al.Therabies virus glycoprotein determines the distribution of diffe-rent rabies virus strain in the brain[J].J Neurovirol,2002,8(4):345-352.
  • 7BLANTON J D,SELF J,NIEZGODA M,et al.Oral vaccina-tion of raccoons(Procyon lotor)with genetically modifiedrabies virus vaccines[J].Vaccine,2007,25(42):7296-7300.
  • 8LIN F T.The protective effective of the large scale use ofPHKC rabies vaccine in human in China[J].Bull WorldHealth Organ,1990,68(4):449-454.
  • 9FABER M,PULMANAUSAHAKUL R,NAGAO K,et al.Identification of viral genomic elements responsible for rabiesvirus neuroinvasiveness[J].Proc Natl Acad Sci USA,2004,101(46):16328-16332.
  • 10DU J,ZHANG Q,TANG Q,et al.Characterization of humanrabies virus vaccine strain in China[J].Virus Res,2008,135(2):260-266.

共引文献6

同被引文献10

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部